|
 |
FollitropinThis page contains recent news articles, when available, and an overview of Follitropin but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Current recombinant (follitropin) as well as highly purified human urinary (urofollitropin) FSH preparations have replaced earlier products with painful IM MarketWatch EMD Serono Launches Landmark Patient Registry for Egg Freezing - Nov 7, 2008 EMD Serono is a leader in fertility treatments, with Gonal-f(R) (follitropin alpha for injection), Luveris(R) (lutropin alfa for injection) and Ovidrel(R) SYS-CON Media, Theratechnologies and EMD Serono Announce Collaboration and ... - Oct 29, 2008 EMD Serono is a leader in fertility treatments, with Gonal-f(R) (follitropin alpha for injection), Luveris(R) (lutropin alfa for injection) and Ovidrel(R) MarketWatch Merck KGaA profits soar as Serono drugs keep growing - Oct 27, 2008 The fertility treatment Gonal F (follitropin) was up 11% to 109 million euros, while the thyroid treatment Euthyrox (levothyroxine) contributed 39 million Pharma Times (registration), EMD Serono Named as a Top Employer by Science Magazine - Oct 9, 2008 EMD Serono is a leader in fertility treatments, with Gonal-f(R) (follitropin alpha for injection), Luveris(R) (lutropin alfa for injection) and Ovidrel(R) MarketWatch Michael J. Fox Foundation Awards $2 Million Grant From EMD Serono ... - Oct 14, 2008 EMD Serono is a leader in fertility treatments, with Gonal-f(R) (follitropin alpha for injection), Luveris(R) (lutropin alfa for injection) and Ovidrel(R) PR Newswire (press release), EMD Serono Named as a Top Employer by Science Magazine - Oct 9, 2008 EMD Serono is a leader in fertility treatments, with Gonal-f(R)(follitropin alpha for injection), Luveris(R) (lutropin alfa for injection)and Ovidrel(R) International Business Times, Assessment of the biopotency of follitropin alfa and lutropin alfa ... - Jul 22, 2008 The current study was designed to determine if follitropin alfa (recombinant human follicle-stimulating hormone; r-hFSH) and lutropin alfa (recombinant 7thSpace Interactive (press release), Schering-Plough's fertility drug meets study end point - Jul 9, 2008 Engage was a non-inferiority, double-blind fertility trial designed to compare corifollitropin alfa 150mcg to 200 IU follitropin beta. Trading Markets (press release), Schering-Plough reports positive phase-three study data - Jul 11, 2008 ...ongoing pregnancy rate with 150 mcg corifollitropin alfa was "similar to that achieved in patients receiving 200 IU recombinant FSH (follitropin beta)". Hays Pharma, EMD Serono to Adopt Revised and Strengthened PhRMA Code - Jul 10, 2008 EMD Serono is a leader in fertility treatments, with Gonal-f(R) (follitropin alpha for injection), Luveris(R) (lutropin alfa for injection) and Ovidrel(R) PR Newswire (press release), InvestSource Inc.: PureSpectrum, Inc. Conducts Performance Testing ... - Jul 9, 2008 ...per started cycle) was similar to that achieved in patients receiving 200 IU recombinant FSH (follitropin beta) (38.1 percent per started cycle). Trading Markets (press release), Erbitux sales soar as Merck KGaA posts first-quarter profit - 23 Apr 2008 The fertility treatment Gonal F (follitropin) sneaked up 1.3% to 114 million euros, while the thyroid treatment Euthyrox (levothyroxine) contributed 35 Pharma Times (subscription), Women Want to Know More About Infertility According to Recent Survey - Apr 17, 2008 EMD Serono is a leader in fertility treatments, with Gonal-f(R) (follitropin alfa for injection), Luveris(R) (lutropin alfa for injection) and Ovidrel(R) PR Newswire (press release), EMD Serono Announces Planned Investment of $50 Million in Research ... - Apr 16, 2008 EMD Serono is a leader in fertility treatments, with Gonal-f(R) (follitropin alpha for injection), Luveris(R) (lutropin alfa for injection) and Ovidrel(R) PR Newswire (press release), Cyberplex Acquires Eidenai Innovations [CX.TO] - Sep 4, 2007 EMD Serono has also agreed to provide certain quantities of two of its products, Gonal-f RFF Pen or follitropin alfa injection and Ovidrel Prefilled Syringe RTT News, ViaCell Announces ViaCyte Collaboration with EMD Serono, Inc. - Sep 4, 2007 In addition, EMD Serono has agreed to provide certain quantities of two of its products, Gonal-f(R) RFF Pen (follitropin alfa injection) and Ovidrel(R) PharmaLive.com (press release), Merck Serono's Fertility Treatment Pergoveris Approved in European ... - Jun 29, 2007 PharmaLive.com (press release),Pergoveris(tm) is the first biotechnology product based on the combination of recombinant human FSH (r-hFSH or follitropin alfa 150IU) and recombinant human EMD Serono Launches MS LifeLines Access Made Simple, a Program ... - Jul 2, 2007 Earthtimes.orgEMD Serono is a world leader in reproductive health, with Gonal-f(R) (follitropin alpha for injection), Luveris(R) (lutropin alfa for injection) and European Union CHMP Recommends Approval of New Formulation of ... - Jun 27, 2007 Earthtimes.orgThe Company is the world leader in reproductive health, with Gonal-f(R) (follitropin alfa for injection), Luveris(R) (lutropin alfa for injection) and Meeting Highlights From The Committee For Medicinal Products For ... - Apr 27, 2007 Medical News Today (press release),Pergoveris (follitropin alfa and lutropin alfa), from Serono Europe Ltd, intended for the stimulation of follicular development in women with severe Committee for Medicinal Products for Human Use Summary of Positive ... - Apr 27, 2007 PharmaLive.com (press release),The active substances of Pergoveris are follitropin alfa (G03GA05) and lutropin alfa (G03GA07), two gonadotrophins produced by genetically engineered : |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines mongabay.com
COPYRIGHT 2007 MONGABAY.COM |